Trial Profile
Gender vs. Fed/Fasted State vs. Capsule/Liquid Suspension Formulation Study .
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Aug 2023
Price :
$35
*
At a glance
- Drugs SRT 2104 (Primary)
- Indications Chronic obstructive pulmonary disease; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; Sirtris
- 05 Aug 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 21 Jul 2009 New trial record